Tim Anderson

Shares of Johnson & Johnson (NYSE:JNJ) are under pressure Thursday, despite a strong second-quarter earnings report. Here are some key analyst takeaways. BofA Securities analyst Tim Anderson reiterated a Neutral rating, while raising the price target from $161 to $175. Guggenheim Securities...

Eli Lilly & Co. (NYSE:LLY) shares staged their sharpest single-day rally in nearly 25 years Thursday, after unveiling data from a pivotal trial that could cement its leadership in a weight-loss drug market projected to more than triple in size by 2030. The stock surged, closing the day up 14....

The year 2024 saw the U.S. stock market make new records, with major indices breaching key milestones. While many stocks witnessed a stellar rally this year, analysts still expect some blue-chip equities to rise further as they forecast a better return potential. Dow’s Performance In 2024 The...

Bernstein upgraded shares of AstraZeneca plc (ADR) (NYSE: AZN), giving four reasons for its optimistic assessment. All the same, the firm also harped on two controversies surrounding the company. As such, Bernstein upgraded shares of AstraZeneca from Market Perform to Outperform and lifted its...

Lung and bronchus cancer is the leading cause of cancer deaths in the United States, according to the National Cancer Institute. Lung cancer is of two types, namely non-small cell lung cancer, or NSCLC and small cell lung cancer, or SCLC, with the former more prevalent than the latter. Estimates by...

Despite the approach of Christmas Day, the beginning of Hanukkah and the start of a new year, some investors are finding joy and excitement elsewhere: the Dow Jones Industrial Average. However, there are those who aren't in the same spirit, wondering what exactly is the true meaning of Dow 20...

Pharmaceutical companies breathed a sigh of relief when Donald Trump prevailed on Election Day. His opponent, Hillary Clinton, had made prescription drug pricing a centerpiece of her campaign. However, according to Bernstein analyst Tim Anderson, pharma stocks may not be off the hook when Trump...

Certain things for certain places leave an impression on you. For me, there is one thing from my time spent on the trading floor at the Chicago Mercantile Exchange from 1985–1992, that will never escape my mind: the paper. In other words, the tremendous of amount of excess paper that covered...

Friday's trading session saw a large spike in high-yield ETF volumes, resulting in single-day record volume. Tim Anderson of TJM Investments said Friday's trading activity was also an exercise in "sell what you can, if not what you want to." Lotfi Karoui of Goldman Sachs noted that 2015 could be...

Tim Anderson was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis Dick. Crude oil prices are down substantially over the past 52 weeks. The United States Oil Fund LP (NYSE: USO) is down 57 percent, while the VelocityShares 3X Long Crude...

In a report published Friday, MND Partners' Tim Anderson noted that Netflix, Inc. (NASDAQ: NFLX) and Google Inc (NASDAQ: GOOG)(NASDAQ: GOOGL) are leading the upside in the NASDAQ and that these stocks are no "House of Cards." Netflix's shares rallied 18 percent on...

Apple Inc. (NASDAQ: AAPL) shares fell more than 2 percent on Thursday amid chatter from Goldman Sachs' trading desk. The bank noted four reasons the tech giant could be trading down -- China, poor Watch demand, smaller buyback and hedge fund/mutual fund activity. On Friday morning, with...

The following is an excerpt from Tim Anderson's morning note. Equity markets are in full rally mode early this morning as initial reports from a meeting of the EU finance ministers is that the latest budget proposals from Greece is enough to serve as a deal. This is no doubt a Very Fluid...